0001676725 2026-05-04 2026-05-04 0001676725 1 2026-05-04 2026-05-04 0001676725 2 2026-05-04 2026-05-04 0001676725 3 2026-05-04 2026-05-04 0001676725 4 2026-05-04 2026-05-04 0001676725 5 2026-05-04 2026-05-04 iso4217:USD pure S-3 S-3ASR EX-FILING FEES 0001676725 IDEAYA Biosciences, Inc. N/A N/A S-3 IDEAYA Biosciences, Inc. false Equity Common Stock, $0.0001 par value per share true 0.0001381 false Equity Preferred Stock, $0.0001 par value per share true 0.0001381 false Debt Debt Securities true 0.0001381 false Other Warrants true 0.0001381 false Other Units true 0.0001381 0.00 0.00 0.00 0.00 0.00 1.a. An unspecified number of securities or aggregate principal amount, as applicable, is being registered as may from time to time be offered at unspecified prices and, in addition, an unspecified number of securities is being registered as may be issued from time to time upon conversion of or exchange for any preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants, or pursuant to any anti-dilution adjustments with respect to any such securities. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. 1.b. Includes rights to acquire common stock or preferred stock under any shareholder rights plan then in effect, if applicable under the terms of any such plan. 1.c. The proposed maximum per security and aggregate offering prices per class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security. 1.d. In accordance with Rules 456(b) and 457(r) under the Securities Act, the registrant is deferring payment of the entire registration fee and will pay such fees subsequently in advance or on a "pay-as-you-go" basis. See notes 1.a., 1.b., 1.c. and 1.d. above. See notes 1.a., 1.c. and 1.d. above. See notes 1.a., 1.c. and 1.d. above. See notes 1.a., 1.c. and 1.d. above.